<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04821466</url>
  </required_header>
  <id_info>
    <org_study_id>2021.RCHT.07</org_study_id>
    <nct_id>NCT04821466</nct_id>
  </id_info>
  <brief_title>VR for Symptom Control and Wellbeing</brief_title>
  <official_title>The Use of Virtual Reality for Symptom Control and Wellbeing in Palliative Care and Oncology Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royal Cornwall Hospitals Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Royal Cornwall Hospitals Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the effect that a Virtual Reality experience can have on patient symptoms and&#xD;
      wellbeing for palliative care and oncology inpatients&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 14, 2021</start_date>
  <completion_date type="Anticipated">April 4, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 4, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Cohort interrupted time series study</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ESAS-r Quality of Life Scores</measure>
    <time_frame>Time 0 &amp; Time 60 minutes</time_frame>
    <description>Change in ESAS-r QoL score between start and finish of Virtual Reality experience. 0 = No symptoms to 10 = Worst Symptom</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantitative clinician experience of VR intervention</measure>
    <time_frame>Time 60 minutes</time_frame>
    <description>Clinician score of patient experience using Virtual Reality intervention for symptoms and wellbeing between 0 (negative) and 10 (positive)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative clinician experience of VR intervention</measure>
    <time_frame>Time 60 minutes</time_frame>
    <description>Patient score of experience using Virtual Reality intervention for symptoms and wellbeing between 0 (negative) and 10 (positive)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Qualitative patient experience of VR interventions</measure>
    <time_frame>Time 60 minutes</time_frame>
    <description>Patients to answer: Were there any negative side effects of the VR session?</description>
  </other_outcome>
  <other_outcome>
    <measure>Repeat VR experiences</measure>
    <time_frame>12 Months</time_frame>
    <description>ESAS-r QoL Scores (0 to 10) will be collected each time a patient uses the experience to consider the effect repeat exposure has on wellbeing and symptoms. 0 = No symptoms to 10 = Worst Symptom</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Oncology</condition>
  <condition>End Stage Cancer</condition>
  <condition>Palliative Care</condition>
  <condition>Hematologic Malignancy</condition>
  <arm_group>
    <arm_group_label>Virtual Reality Headset</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>VR headset, programmed with a selection of 7 wellbeing programs to identify if use will improve participants wellbeing</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Virtual Reality Headset to provide a Virtual Reality Experience</intervention_name>
    <description>Participants will utilise a Virtual Reality experience for distraction therapy via a Virtual reality headset. Participants will wear the Virtual reality headset to be immersed in a multimedia experience.</description>
    <arm_group_label>Virtual Reality Headset</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria&#xD;
&#xD;
          -  &gt; 18 years of age&#xD;
&#xD;
          -  Inpatient at RCHT know to the palliative care team&#xD;
&#xD;
          -  Able to consent&#xD;
&#xD;
          -  Able to speak and understand the English language&#xD;
&#xD;
          -  Able to use the virtual reality system&#xD;
&#xD;
          -  Able to complete ESAS-r Questionnaire&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
          -  &lt;18 years of age&#xD;
&#xD;
          -  Patient unable to consent&#xD;
&#xD;
          -  Patient unable to speak English&#xD;
&#xD;
          -  Unable to use the virtual reality system (e.g. visually impaired)&#xD;
&#xD;
          -  Known Epilepsy or seizures or suspected predisposition to seizures (e.g. Brain&#xD;
             metastasis)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Niall O Moon, BMBCh</last_name>
    <role>Principal Investigator</role>
    <affiliation>Doctor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Niall O Moon, BMBCh</last_name>
    <phone>01872 256347</phone>
    <phone_ext>6347</phone_ext>
    <email>niall.moon@nhs.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>John McGrane, MBChB</last_name>
    <phone>01872 256347</phone>
    <phone_ext>6347</phone_ext>
    <email>john.mcgrane@nhs.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Royal Cornwall Hospital</name>
      <address>
        <city>Truro</city>
        <state>Cornwall</state>
        <zip>TR1 3HD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nial Moon</last_name>
    </contact>
    <contact_backup>
      <last_name>John McGrane</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 23, 2021</study_first_submitted>
  <study_first_submitted_qc>March 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2021</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Virtual Reality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Hematologic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plan to share patient data</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

